About the Product

Description


Flunafeb D Tablet containing Flunarizine and Domperidone is used for the management of migraine and vertigo-related conditions. It helps reduce the frequency of migraine attacks and supports relief from associated symptoms such as nausea and dizziness.

Flunarizine works as a calcium channel blocker that helps improve cerebral blood flow and reduces migraine frequency, while Domperidone acts as an antiemetic that helps control nausea and vomiting associated with vertigo and migraine episodes.

The tablet is widely prescribed in neurology practice for migraine prophylaxis and vertigo management, leading to consistent prescription demand.

With the increasing prevalence of neurological disorders and growing demand for effective migraine and vertigo therapies, this product offers strong business potential for retailers and distributors. Its combination formulation, established clinical relevance, and steady market demand make it a reliable product for growth in the neuro care segment.

Some patients may experience drowsiness, weight gain, dry mouth, fatigue, increased appetite, constipation, or dizziness. Rarely, extrapyramidal symptoms, depression, cardiac rhythm disturbances, or galactorrhea may occur and require medical attention.

Flunafeb D Tablet is indicated for migraine prophylaxis, vestibular disorders, vertigo associated with nausea, motion sickness, and migraine-related vomiting. It helps reduce the frequency and severity of migraine attacks and improves associated symptoms like dizziness and nausea.

This medicine should be used strictly under medical supervision. Use cautiously in patients with depression, Parkinson’s disease, liver impairment, or a history of movement disorders. Avoid prolonged use without medical review. Domperidone should be used carefully in patients with cardiac risk factors due to possible effects on heart rhythm.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions